Annual Cash & Cash Equivalents
$37.32 M
-$14.48 M-27.96%
December 31, 2023
Summary
- As of February 6, 2025, KURA annual cash & cash equivalents is $37.32 million, with the most recent change of -$14.48 million (-27.96%) on December 31, 2023.
- During the last 3 years, KURA annual cash & cash equivalents has fallen by -$288.18 million (-88.53%).
- KURA annual cash & cash equivalents is now -88.53% below its all-time high of $325.49 million, reached on December 31, 2020.
Performance
KURA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$49.48 M
+$4.30 M+9.51%
September 30, 2024
Summary
- As of February 6, 2025, KURA quarterly cash and cash equivalents is $49.48 million, with the most recent change of +$4.30 million (+9.51%) on September 30, 2024.
- Over the past year, KURA quarterly cash and cash equivalents has increased by +$12.16 million (+32.59%).
- KURA quarterly cash and cash equivalents is now -84.80% below its all-time high of $325.49 million, reached on December 31, 2020.
Performance
KURA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KURA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.0% | +32.6% |
| 3 y3 years | -88.5% | +32.6% |
| 5 y5 years | +131.5% | +32.6% |
KURA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.8% | at low | -45.6% | +82.9% |
| 5 y | 5-year | -88.5% | +42.8% | -84.8% | +89.3% |
| alltime | all time | -88.5% | +3220.1% | -84.8% | +629.5% |
Kura Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $49.48 M(+9.5%) |
| Jun 2024 | - | $45.18 M(+8.9%) |
| Mar 2024 | - | $41.51 M(+11.2%) |
| Dec 2023 | $37.32 M(-28.0%) | $37.32 M(+29.8%) |
| Sep 2023 | - | $28.74 M(-41.5%) |
| Jun 2023 | - | $49.12 M(+81.5%) |
| Mar 2023 | - | $27.06 M(-47.8%) |
| Dec 2022 | $51.80 M(-42.9%) | $51.80 M(-43.0%) |
| Sep 2022 | - | $90.94 M(+131.6%) |
| Jun 2022 | - | $39.26 M(+16.0%) |
| Mar 2022 | - | $33.83 M(-62.7%) |
| Dec 2021 | $90.67 M(-72.1%) | $90.67 M(+131.4%) |
| Sep 2021 | - | $39.18 M(+0.5%) |
| Jun 2021 | - | $38.97 M(-64.8%) |
| Mar 2021 | - | $110.83 M(-65.9%) |
| Dec 2020 | $325.49 M(+1145.4%) | $325.49 M(+323.0%) |
| Sep 2020 | - | $76.95 M(-42.9%) |
| Jun 2020 | - | $134.76 M(+298.6%) |
| Mar 2020 | - | $33.81 M(+29.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $26.14 M(+62.1%) | $26.14 M(-52.3%) |
| Sep 2019 | - | $54.74 M(-55.2%) |
| Jun 2019 | - | $122.08 M(+586.7%) |
| Mar 2019 | - | $17.78 M(+10.3%) |
| Dec 2018 | $16.12 M(+41.0%) | $16.12 M(-21.6%) |
| Sep 2018 | - | $20.57 M(+16.5%) |
| Jun 2018 | - | $17.66 M(-33.4%) |
| Mar 2018 | - | $26.52 M(+131.9%) |
| Dec 2017 | $11.43 M(+17.6%) | $11.43 M(-51.0%) |
| Sep 2017 | - | $23.34 M(+92.0%) |
| Jun 2017 | - | $12.15 M(+14.2%) |
| Mar 2017 | - | $10.64 M(+9.4%) |
| Dec 2016 | $9.72 M(-37.0%) | $9.72 M(+43.4%) |
| Sep 2016 | - | $6.78 M(-44.0%) |
| Jun 2016 | - | $12.11 M(-25.8%) |
| Mar 2016 | - | $16.33 M(+5.7%) |
| Dec 2015 | $15.44 M(+1273.9%) | $15.44 M(+37.7%) |
| Sep 2015 | - | $11.21 M |
| Dec 2014 | $1.12 M | - |
FAQ
- What is Kura Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kura Oncology?
- What is Kura Oncology annual cash & cash equivalents year-on-year change?
- What is Kura Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kura Oncology?
- What is Kura Oncology quarterly cash and cash equivalents year-on-year change?
What is Kura Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of KURA is $37.32 M
What is the all time high annual cash & cash equivalents for Kura Oncology?
Kura Oncology all-time high annual cash & cash equivalents is $325.49 M
What is Kura Oncology annual cash & cash equivalents year-on-year change?
Over the past year, KURA annual cash & cash equivalents has changed by -$14.48 M (-27.96%)
What is Kura Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KURA is $49.48 M
What is the all time high quarterly cash and cash equivalents for Kura Oncology?
Kura Oncology all-time high quarterly cash and cash equivalents is $325.49 M
What is Kura Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, KURA quarterly cash and cash equivalents has changed by +$12.16 M (+32.59%)